Simplex Trading
PLRX icon

Simplex Trading’s Pliant Therapeutics PLRX Stock Holding History

Simplex Trading’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.2K Buy
65,200
+45,600
+233% +$57.6K ﹤0.01% 5315
2025
Q4 		$23.9K Buy
19,600
+13,400
+216% +$20.1K ﹤0.01% 6312
2025
Q3 		$9K Sell
6,200
-600
-9% -$915 ﹤0.01% 7980
2025
Q2 		$7K Buy
+6,800
New +$9.61K ﹤0.01% 7575
2025
Q1 		– Sell
-9,200
Closed -$121K – 9389
2024
Q4 		$121K Sell
9,200
-500
-5% -$6.83K ﹤0.01% 5003
2024
Q3 		$108K Buy
9,700
+6,700
+223% +$83.8K ﹤0.01% 5150
2024
Q2 		$32K Buy
3,000
+700
+30% +$9.02K ﹤0.01% 6506
2024
Q1 		$34K Buy
2,300
+2,200
+2,200% +$36.3K ﹤0.01% 6650
2023
Q4 		$1K Sell
100
-14,700
-99% -$224K ﹤0.01% 8554
2023
Q3 		$256K Buy
14,800
+14,700
+14,700% +$255K ﹤0.01% 4101
2023
Q2 		$1K Sell
100
-5,200
-98% -$123K ﹤0.01% 8694
2023
Q1 		$140K Buy
5,300
+3,600
+212% +$102K ﹤0.01% 4765
2022
Q4 		$32K Sell
1,700
-500
-23% -$10.5K ﹤0.01% 6386
2022
Q3 		$45K Buy
+2,200
New +$42.1K ﹤0.01% 6601

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Simplex Trading's PLRX Position: Q1 2026 in Review

Simplex Trading increased its Pliant Therapeutics (PLRX) stake by 4.7% in Q1 2026, buying an estimated $2.7K and bringing the position to 48,054 shares worth $60.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5658.

Simplex Trading first reported a position in PLRX in Q1 2022 and has held it in 15 quarters since. The position peaked at $444K in Q3 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Simplex Trading held 48,054 shares of Pliant Therapeutics worth $60.5K as of Q1 2026.
  • Simplex Trading bought 2,142 Pliant Therapeutics shares in Q1 2026, an estimated $2.7K.
  • Pliant Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5658 holding.
  • Simplex Trading first reported a position in Pliant Therapeutics in Q1 2022 and has held it in 15 quarters since.
  • Simplex Trading's Pliant Therapeutics position peaked at $444K in Q3 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.